These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 11396974

  • 1. Antiproliferative effects of nitrosulindac on human colon adenocarcinoma cell lines.
    Lavagna C, Burgaud JL, Del Soldato P, Rampal P.
    Biochem Biophys Res Commun; 2001 Jun 15; 284(3):808-16. PubMed ID: 11396974
    [Abstract] [Full Text] [Related]

  • 2. Nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NSAIDs) alter the kinetics of human colon cancer cell lines more effectively than traditional NSAIDs: implications for colon cancer chemoprevention.
    Williams JL, Borgo S, Hasan I, Castillo E, Traganos F, Rigas B.
    Cancer Res; 2001 Apr 15; 61(8):3285-9. PubMed ID: 11309281
    [Abstract] [Full Text] [Related]

  • 3. Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction.
    Piazza GA, Rahm AK, Finn TS, Fryer BH, Li H, Stoumen AL, Pamukcu R, Ahnen DJ.
    Cancer Res; 1997 Jun 15; 57(12):2452-9. PubMed ID: 9192825
    [Abstract] [Full Text] [Related]

  • 4. Nitrosulindac (NCX 1102): a new nitric oxide-donating non-steroidal anti-inflammatory drug (NO-NSAID), inhibits proliferation and induces apoptosis in human prostatic epithelial cell lines.
    Huguenin S, Fleury-Feith J, Kheuang L, Jaurand MC, Bolla M, Riffaud JP, Chopin DK, Vacherot F.
    Prostate; 2004 Oct 01; 61(2):132-41. PubMed ID: 15305336
    [Abstract] [Full Text] [Related]

  • 5. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells.
    Sun Y, Tang XM, Half E, Kuo MT, Sinicrope FA.
    Cancer Res; 2002 Nov 01; 62(21):6323-8. PubMed ID: 12414664
    [Abstract] [Full Text] [Related]

  • 6. Modulation of inducible nitric oxide synthase and related proinflammatory genes by the omega-3 fatty acid docosahexaenoic acid in human colon cancer cells.
    Narayanan BA, Narayanan NK, Simi B, Reddy BS.
    Cancer Res; 2003 Mar 01; 63(5):972-9. PubMed ID: 12615711
    [Abstract] [Full Text] [Related]

  • 7. Sulindac and exisulind exhibit a significant antiproliferative effect and induce apoptosis in human hepatocellular carcinoma cell lines.
    Rahman MA, Dhar DK, Masunaga R, Yamanoi A, Kohno H, Nagasue N.
    Cancer Res; 2000 Apr 15; 60(8):2085-9. PubMed ID: 10786664
    [Abstract] [Full Text] [Related]

  • 8. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model.
    Narayanan BA, Narayanan NK, Pittman B, Reddy BS.
    Clin Cancer Res; 2004 Nov 15; 10(22):7727-37. PubMed ID: 15570007
    [Abstract] [Full Text] [Related]

  • 9. NCX 4016, a nitric oxide-releasing aspirin derivative, exhibits a significant antiproliferative effect and alters cell cycle progression in human colon adenocarcinoma cell lines.
    Tesei A, Ricotti L, Ulivi P, Medri L, Amadori D, Zoli W.
    Int J Oncol; 2003 Jun 15; 22(6):1297-302. PubMed ID: 12738997
    [Abstract] [Full Text] [Related]

  • 10. Sulindac enhances tumor necrosis factor-alpha-mediated apoptosis of lung cancer cell lines by inhibition of nuclear factor-kappaB.
    Berman KS, Verma UN, Harburg G, Minna JD, Cobb MH, Gaynor RB.
    Clin Cancer Res; 2002 Feb 15; 8(2):354-60. PubMed ID: 11839649
    [Abstract] [Full Text] [Related]

  • 11. Cyclooxygenase-2 overexpression inhibits death receptor 5 expression and confers resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human colon cancer cells.
    Tang X, Sun YJ, Half E, Kuo MT, Sinicrope F.
    Cancer Res; 2002 Sep 01; 62(17):4903-8. PubMed ID: 12208739
    [Abstract] [Full Text] [Related]

  • 12. Prostaglandin-independent effects of aspirin on cell cycle and putrescine synthesis in human colon carcinoma cells.
    Eklou-Kalonji E, Andriamihaja M, Reinaud P, Mayeur C, Camous S, Robert V, Charpigny G, Blachier F.
    Can J Physiol Pharmacol; 2003 May 01; 81(5):443-50. PubMed ID: 12774850
    [Abstract] [Full Text] [Related]

  • 13. Benzylamide sulindac analogues induce changes in cell shape, loss of microtubules and G(2)-M arrest in a chronic lymphocytic leukemia (CLL) cell line and apoptosis in primary CLL cells.
    Moon EY, Lerner A.
    Cancer Res; 2002 Oct 15; 62(20):5711-9. PubMed ID: 12384529
    [Abstract] [Full Text] [Related]

  • 14. NO-donating nonsteroidal antiinflammatory drugs (NSAIDs) inhibit colon cancer cell growth more potently than traditional NSAIDs: a general pharmacological property?
    Yeh RK, Chen J, Williams JL, Baluch M, Hundley TR, Rosenbaum RE, Kalala S, Traganos F, Benardini F, del Soldato P, Kashfi K, Rigas B.
    Biochem Pharmacol; 2004 Jun 15; 67(12):2197-205. PubMed ID: 15163551
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of COX-2 in colon cancer cell lines by celecoxib increases the nuclear localization of active p53.
    Swamy MV, Herzog CR, Rao CV.
    Cancer Res; 2003 Sep 01; 63(17):5239-42. PubMed ID: 14500353
    [Abstract] [Full Text] [Related]

  • 16. Cyclooxygenase-2 (COX-2)-dependent and -independent anticarcinogenic effects of celecoxib in human colon carcinoma cells.
    Maier TJ, Schilling K, Schmidt R, Geisslinger G, Grösch S.
    Biochem Pharmacol; 2004 Apr 15; 67(8):1469-78. PubMed ID: 15041464
    [Abstract] [Full Text] [Related]

  • 17. Anthocyanin-rich extract from Aronia meloncarpa E induces a cell cycle block in colon cancer but not normal colonic cells.
    Malik M, Zhao C, Schoene N, Guisti MM, Moyer MP, Magnuson BA.
    Nutr Cancer; 2003 Apr 15; 46(2):186-96. PubMed ID: 14690795
    [Abstract] [Full Text] [Related]

  • 18. Growth inhibition of human colon cancer cells by nitric oxide (NO)-donating aspirin is associated with cyclooxygenase-2 induction and beta-catenin/T-cell factor signaling, nuclear factor-kappaB, and NO synthase 2 inhibition: implications for chemoprevention.
    Williams JL, Nath N, Chen J, Hundley TR, Gao J, Kopelovich L, Kashfi K, Rigas B.
    Cancer Res; 2003 Nov 15; 63(22):7613-8. PubMed ID: 14633677
    [Abstract] [Full Text] [Related]

  • 19. [COX-2 inhibitor and colon cancer].
    Tsujii M.
    Gan To Kagaku Ryoho; 2001 Nov 15; 28(12):1799-805. PubMed ID: 11729471
    [Abstract] [Full Text] [Related]

  • 20. Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-kappaB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation.
    Takada Y, Bhardwaj A, Potdar P, Aggarwal BB.
    Oncogene; 2004 Dec 09; 23(57):9247-58. PubMed ID: 15489888
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.